ArticleSmall methods2025
Rapid and Sensitive Detection of RNA Viruses through Imaging of Marker Molecules Derived from Designed Circular DNA Probes.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- SEM mapping of sequence-specific protein-DNA interactions on long DNA molecules.Nucleic acids research · 2026Article
- Metal- and polymer-assisted SEM imaging of protein-bound DNA molecules: a protocol.Biology methods & protocols · 2026Review
- Circular nucleic acids at the host-virus interface: from immune modulation to therapeutic innovation.Frontiers in immunology · 2026Review
- Rapid and Sensitive Detection of RNA Viruses through Imaging of Marker Molecules Derived from Designed Circular DNA Probes.Small methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
In the absence of treatment, detection of pathogenic RNA viruses and quarantine of infected individuals are critical for controlling the infection spread. Conventional antibody-based methods often lack the required accuracy and sensitivity, due to the need for a substantial amount of viral antigens. Similarly, traditional reverse transcription real-time polymerase chain reaction methods face challenges in providing timely results due to their multiple thermal nucleic acid amplification steps. To overcome these limitations, a new method based on imaging of virus-specific DNA markers is developed. This approach employs specially designed single-stranded circular DNA probes that capture virus-derived RNA fragments generated by RNase digestion of the viral genome. These fragments serve as primers for a subsequent single-step DNA filling reaction, producing double-stranded virus-specific marker molecules. These individual markers are recognized through fluorescence imaging following linearization by enzyme cleavage and subsequent fluorescence staining. This method can detect viruses at a genome equivalent level of 14 within 40 min. In addition, the molecule-level imaging-based method effectively detects human immunodeficiency virus-1 in clinical samples. This diagnostic approach does not require sophisticated thermal controls nor extensive nucleic acid amplifications, allowing for accurate, sensitive, and rapid detection without the need for large equipment, offering substantial potential for point-of-care applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.